
Align Technology (ALGN) Stock Forecast & Price Target
Align Technology (ALGN) Analyst Ratings
Bulls say
Align Technology is positioned well in the market, with a dominant clear aligner product that has treated over 14 million patients since its launch. The company's global market appears under-penetrated, and their digital software and intraoral scanners further differentiate their offerings. While there are potential risks, the company's international growth and stable performance in the U.S. support their 2026 guidance, and our analysis suggests an upward bias to future results.
Bears say
Align Technology is showing strong financial performance with a 5% year-over-year revenue increase in the last quarter and an EPS beat by $0.32. While they have a dominant market share and a large number of trained dentists and orthodontists, the company faces potential competition in the clear aligner market as other companies begin to enter the space. Additionally, relying heavily on digital scans and intraoral scanners may pose a risk if there are any technological issues or advancements in this technology from competitors.
This aggregate rating is based on analysts' research of Align Technology and is not a guaranteed prediction by Public.com or investment advice.
Align Technology (ALGN) Analyst Forecast & Price Prediction
Start investing in Align Technology (ALGN)
Order type
Buy in
Order amount
Est. shares
0 shares